Versant Venture Capital VI, L.P. Insider Trading $OYST Oyster Point Pharma, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Versant Venture Capital VI, L.P..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Versant Venture Capital VI, L.P.. Versant Venture Capital VI, L.P. is 10% Owner in Black Diamond Therapeutics, Inc. ($BDTX) and 10% Owner in Oyster Point Pharma, Inc. ($OYST) and 10% Owner in Akero Therapeutics, Inc. ($AKRO) and 10% Owner in Aligos Therapeutics, Inc. ($ALGS) and 10% Owner in Pandion Therapeutics, Inc. ($PAND).
Versant Venture Capital VI, L.P. in Oyster Point Pharma, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Versant Venture Capital VI, L.P.: 10% Owner
Holdings: 1,681,930 shares
Latest Transaction: Mar 30 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Versant Venture Capital VI, L.P. in Oyster Point Pharma, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AKRO, ALGS, BDTX, OYST, PAND
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 30 2021 | OYST | Oyster Point Pharm ... | Versant Venture Capital VI, L. ... | 10% Owner | Sell | J | 0.00 | 1,990 | 0 | 10,448 | 12.4 K to 10.4 K (-16.00 %) |
| Mar 30 2021 | OYST | Oyster Point Pharm ... | Versant Venture Capital VI, L. ... | 10% Owner | Sell | J | 0.00 | 82,491 | 0 | 0 | 82.5 K to 0 (-100.00 %) |
| Mar 30 2021 | OYST | Oyster Point Pharm ... | Versant Venture Capital VI, L. ... | 10% Owner | Buy | J | 0.00 | 82,491 | 0 | 82,491 | 0 to 82.5 K |
| Mar 30 2021 | OYST | Oyster Point Pharm ... | Versant Venture Capital VI, L. ... | 10% Owner | Sell | J | 0.00 | 320,368 | 0 | 1,681,930 | 2 M to 1.7 M (-16.00 %) |
| Feb 19 2021 | OYST | Oyster Point Pharm ... | Versant Venture Capital VI, L. ... | 10% Owner | Sell | J | 0.00 | 5,607 | 0 | 0 | 5.6 K to 0 (-100.00 %) |
| Feb 19 2021 | OYST | Oyster Point Pharm ... | Versant Venture Capital VI, L. ... | 10% Owner | Buy | J | 0.00 | 5,607 | 0 | 5,607 | 0 to 5.6 K |
| Feb 19 2021 | OYST | Oyster Point Pharm ... | Versant Venture Capital VI, L. ... | 10% Owner | Sell | J | 0.00 | 6,500 | 0 | 0 | 6.5 K to 0 (-100.00 %) |
| Feb 19 2021 | OYST | Oyster Point Pharm ... | Versant Venture Capital VI, L. ... | 10% Owner | Buy | J | 0.00 | 6,500 | 0 | 6,500 | 0 to 6.5 K |
| Feb 19 2021 | OYST | Oyster Point Pharm ... | Versant Venture Capital VI, L. ... | 10% Owner | Sell | J | 0.00 | 325,000 | 0 | 2,236,888 | 2.6 M to 2.2 M (-12.69 %) |
| Nov 04 2019 | OYST | Oyster Point Pharm ... | Versant Venture Capital VI, L. ... | 10% Owner | Option Exercise | C | 0.00 | 566,158 | 0 | 0 | |
| Nov 04 2019 | OYST | Oyster Point Pharm ... | Versant Venture Capital VI, L. ... | 10% Owner | Option Exercise | C | 0.00 | 495,388 | 0 | 0 | |
| Nov 04 2019 | OYST | Oyster Point Pharm ... | Versant Venture Capital VI, L. ... | 10% Owner | Option Exercise | C | 0.00 | 1,941,500 | 0 | 0 | |
| Nov 04 2019 | OYST | Oyster Point Pharm ... | Versant Venture Capital VI, L. ... | 10% Owner | Option Exercise | C | 0.00 | 1,654,359 | 0 | 0 | |
| Nov 04 2019 | OYST | Oyster Point Pharm ... | Versant Venture Capital VI, L. ... | 10% Owner | Option Exercise | C | 0.00 | 10,420 | 0 | 0 | |
| Nov 04 2019 | OYST | Oyster Point Pharm ... | Versant Venture Capital VI, L. ... | 10% Owner | Buy | P | 16.00 | 437,500 | 7,000,000 | 1,003,658 | 566.2 K to 1 M (+77.28 %) |
| Nov 04 2019 | OYST | Oyster Point Pharm ... | Versant Venture Capital VI, L. ... | 10% Owner | Buy | C | 0.00 | 566,158 | 0 | 566,158 | 0 to 566.2 K |
| Nov 04 2019 | OYST | Oyster Point Pharm ... | Versant Venture Capital VI, L. ... | 10% Owner | Buy | P | 16.00 | 125,000 | 2,000,000 | 2,561,888 | 2.4 M to 2.6 M (+5.13 %) |
| Nov 04 2019 | OYST | Oyster Point Pharm ... | Versant Venture Capital VI, L. ... | 10% Owner | Buy | C | 0.00 | 495,388 | 0 | 2,436,888 | 1.9 M to 2.4 M (+25.52 %) |
| Nov 04 2019 | OYST | Oyster Point Pharm ... | Versant Venture Capital VI, L. ... | 10% Owner | Buy | C | 0.00 | 1,941,500 | 0 | 1,941,500 | 0 to 1.9 M |
| Nov 04 2019 | OYST | Oyster Point Pharm ... | Versant Venture Capital VI, L. ... | 10% Owner | Buy | P | 16.00 | 27,500 | 440,000 | 2,002,298 | 2 M to 2 M (+1.39 %) |
| Nov 04 2019 | OYST | Oyster Point Pharm ... | Versant Venture Capital VI, L. ... | 10% Owner | Buy | C | 0.00 | 1,654,359 | 0 | 1,974,798 | 320.4 K to 2 M (+516.28 %) |
| Nov 04 2019 | OYST | Oyster Point Pharm ... | Versant Venture Capital VI, L. ... | 10% Owner | Buy | C | 0.00 | 10,420 | 0 | 12,438 | 2 K to 12.4 K (+516.35 %) |
Page: 1